Search Results - "Dornbusch, K."

Refine Results
  1. 1
  2. 2

    Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae by MONSTEIN, H.-J., ÖSTHOLM-BALKHED, Å., NILSSON, M. V., NILSSON, M., DORNBUSCH, K., NILSSON, L. E.

    “…Extended‐spectrum β‐lactamases (ESBLs) are often mediated by bla‐SHV, blaTEM and blaCTX‐M genes in Enterobacteriaceae and other Gram‐negative bacteria…”
    Get full text
    Journal Article
  3. 3

    Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin by FENDUKLY, F., KARLSSON, I., HANSON, H. S., KRONVALL, G., DORNBUSCH, K.

    “…Thirty‐two Escherichia coli and 21 Klebsiella pneumoniae septicemia isolates with varying degrees of resistance to ciprofloxacin were analyzed for the presence…”
    Get full text
    Journal Article
  4. 4

    Molecular Epidemiology of Extended-Spectrum β-Lactamases among Escherichia coli Isolates Collected in a Swedish Hospital and Its Associated Health Care Facilities from 2001 to 2006 by Fang, Hong, Ataker, Ferda, Hedin, Göran, Dornbusch, Kathrine

    Published in Journal of Clinical Microbiology (01-02-2008)
    “…The genetic characteristics and molecular epidemiology of extended-spectrum β-lactamases (ESBLs) among Escherichia coli isolates were investigated at a general…”
    Get full text
    Journal Article
  5. 5

    Cefepime as Empirical Monotherapy in Febrile Patients with Hematological Malignancies and Neutropenia: A Randomized, Single-Center Phase II Trial by Engervall, P., Kalin, M., Dornbusch, K., Björkholm, M.

    “…The purpose of this phase II trial was to evaluate the efficacy and safety of cefepime monotherapy in patients with neutropenia expected to last more than 7…”
    Get full text
    Journal Article
  6. 6

    Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method by Hallander, H O, Dornbusch, K, Gezelius, L, Jacobson, K, Karlsson, I

    Published in Antimicrobial Agents and Chemotherapy (01-11-1982)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  7. 7

    Metabolism of 2,3-dichloro-1-propene in the rat. Consideration of bioactivation mechanisms by Eder, E, Dornbusch, K

    Published in Drug metabolism and disposition (01-01-1988)
    “…At the present time, comprehensive metabolism studies of 2,3-dichloro-1-propene (2,3-DCP) have not yet been reported. We have investigated the…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Extended spectrum beta-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family by Wu, S W, Dornbusch, K, Norgren, M, Kronvall, G

    Published in Journal of antimicrobial chemotherapy (01-07-1992)
    “…In clinical isolates of Klebsiella oxytoca resistance to cefuroxime and aztreonam was mediated by a beta-lactamase, designated KH, (pI 5.25) which could be…”
    Get more information
    Journal Article
  10. 10

    Distribution and resistance patterns of Haemophilus influenzae: a European cooperative study by Machka, K, Braveny, I, Dabernat, H, Dornbusch, K, Van Dyck, E, Kayser, F H, Van Klingeren, B, Mittermayer, H, Perea, E, Powell, M

    “…The first European survey of the prevalence of antibiotic resistance in Haemophilus influenzae was conducted between February and October 1986. Eighty…”
    Get full text
    Journal Article
  11. 11

    Susceptibility testing of Klebsiella spp.-an international collaborative study in quality assessment by JENKS, P. J, AKALIN, E, PERCIVAL, A, PHILLIPS, I, REEVES, D. S, SPENCER, R, VATOPOULOS, A. C, WARREN, R, WILLIAMS, J. D, BERGAN, T, DORNBUSCH, K, HOWARD, A. J, HRYNIEWICZ, W, JONES, J. R. N, KING, A, MCLAUGHLIN, J. C, OZKUYUMCU, C

    Published in Journal of antimicrobial chemotherapy (01-07-1998)
    “…In order to compare the prevalence of antibiotic resistance in different geographical areas, it is necessary to ensure agreement between laboratories on the…”
    Get full text
    Journal Article
  12. 12

    Laboratory- and species-specific interpretive breakpoints for disk diffusion tests of chloramphenicol susceptibility of Haemophilus influenzae by KRONVALL, G, RINGERTZ, S, KARLSSON, I, GORANSSON, E, DORNBUSCH, K

    Published in Antimicrobial Agents and Chemotherapy (01-10-1988)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  13. 13
  14. 14

    In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of beta-lactamases by Dornbusch, K, Kronvall, G, Göransson, E, Mörtsell, E

    Published in Journal of antimicrobial chemotherapy (01-03-1989)
    “…FCE 22101 is a new penem with broad antibacterial spectrum, excluding the pseudomonads, and has stability to many beta-lactamases. FCE 22101 and imipenem were…”
    Get more information
    Journal Article
  15. 15

    Characterization of Klebsiella oxytoca septicaemia isolates resistant to aztreonam and cefuroxime by Wu, S W, Dornbusch, K, Göransson, E, Ransjö, U, Kronvall, G

    Published in Journal of antimicrobial chemotherapy (01-09-1991)
    “…Eleven clinical isolates of Klebsiella oxytoca from Stockholm hospitals were found to be resistant to aztreonam and cefuroxime, but susceptible to cefotaxime,…”
    Get more information
    Journal Article
  16. 16

    In-vitro activity of the new penems FCE 22101 and FCE 24362 alone or in combination with aminoglycosides against streptococci isolated from patients with endocarditis by Dornbusch, K, Henning, C, Lindén, E

    “…Seven strains of viridans streptococci isolated from patients with endocarditis were inhibited in vitro by 0.06-2 mg/l and 0.016-0.5 mg/l of the penems FCE…”
    Get more information
    Journal Article
  17. 17

    Synergy and cumulated killing effect of the penems FCE 22101 and FCE 25199 in combination with gentamicin against bacteria isolated from septicaemia by Bergholm, A M, Dornbusch, K

    “…Blood isolates of Enterococcus faecalis, Streptococcus sanguis, Staphylococcus aureus, E. coli and Klebsiella oxytoca were tested for their synergistic and…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Comparative in-vitro activity of the penem FCE 22101 against recent European blood culture isolates by Dornbusch, K, Kronvall, G, Göransson, E, Mörtsell, E

    “…Recent blood culture isolates (462 strains of Gram-negative bacilli and 288 strains of staphylococci) collected in 30 European laboratories were tested for…”
    Get more information
    Journal Article
  20. 20

    Antibiotic susceptibility and beta-lactamase production in clinical isolates of Enterobacter spp by Lindh, E, Dornbusch, K, Jalakas, K, Forsgren, A

    “…The in vitro susceptibility of 237 clinical isolates of Enterobacter spp. (E. aerogenes, E. agglomerans and E. cloacae; 41, 64 and 132 respectively) to 16…”
    Get more information
    Journal Article